title: Vitamin D absorption, plasma concentration and urinary excretion of 25-hydroxyvitamin D in nephrotic syndrome.
abstract: Nephrotic syndrome (NS) is commonly associated with vitamin D deficiency. Urinary losses of the protein-bound intermediary metabolite of this vitamin is thought to contribute to the deficiency state. The role of possible changes, if any, of vitamin D absorption has not been investigated previously in NS. We determined intestinal absorption of vitamin D3 as well as plasma concentration and urinary excretion of 25-hydroxyvitamin D3 in rats with puromycin aminonucleoside-induced NS. In vivo recirculating perfusion technique was employed at 100 and 600 nM perfusate concentrations. The results were compared with those obtained in animals receiving placebo injections provided with either free access to food (normal controls) or those pair-fed with their NS counterparts (pair-fed group). The NS group showed heavy proteinuria and hypoalbuminemia. In addition, the NS group exhibited marked urinary losses and significantly reduced plasma concentration of 25-hydroxyvitamin D. The rate of vitamin D3 absorption (given as nmol/100 cm/min) at 100 nM perfusate concentration in the NS group (0.161 +/- 0.029) was not significantly different from those obtained in the pair-fed group (0.202 +/- 0.058) and the normal control group (0.143 +/- 0.053). Likewise, no significant difference was found in the rats of vitamin D absorption at 600 nM concentration among the NS (1.073 +/- 0.383), pair-fed (0.955 +/- 0.229), and normal control (0.756 +/- 0.314) groups. Accordingly, intestinal absorption of vitamin D appears to be unaffected by the presence of experimental NS and as such the associated vitamin D deficiency can be managed by enteral supplementation.
authors.affiliation: Department of Medicine, University of California, Irvine 92717.
authors.forename: G
authors.initials: G
authors.lastname: Khamiseh
authors.forename: N D
authors.initials: ND
authors.lastname: Vaziri
authors.forename: F
authors.initials: F
authors.lastname: Oveisi
authors.forename: M R
authors.initials: MR
authors.lastname: Ahmadnia
authors.forename: L
authors.initials: L
authors.lastname: Ahmadnia
mesh_terms: D000042:Absorption; D000818:Animals; D001794:Blood Pressure; D001835:Body Weight; D002112:Calcifediol / Q000378:metabolism*; D002118:Calcium / Q000097:blood; D003404:Creatinine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D007413:Intestinal Mucosa / Q000378:metabolism; D008297:Male; D009404:Nephrotic Syndrome / Q000378:metabolism*; D011507:Proteinuria; D051381:Rats; D011919:Rats, Inbred Strains; D012709:Serum Albumin / Q000032:analysis; D014807:Vitamin D / Q000493:pharmacokinetics*
chemical_list: D012709:Serum Albumin; D014807:Vitamin D; D003404:Creatinine; D002112:Calcifediol; D002118:Calcium